Literature DB >> 35819695

Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis.

Han-Qi Zhang1,2, Si-Wei Yang1,2, Yi-Cheng Fu1, Ming-Cong Chen1, Cheng-Hao Yang1,2, Ming-Hua Yang1, Xiao-Dan Liu3, Qing-Nan He4, Hua Jiang5, Ming-Yi Zhao6.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening systemic hyperinflammatory syndrome. The central pathogenesis is an explosive cytokine storm characterized by a significant increase in proinflammatory cytokines, including IL-1β, IL-6, IL-18, IFN-γ, and TNF-α. Meanwhile, negative regulatory factors, such as IL-10 and TGF-β, are also related to the production of HLH. Exploring the specific mechanism of cytokine storms could provide ideas regarding targeted therapy, which could be helpful for early treatment to reduce the mortality of HLH. Although some research has focused on the advantages of targeted therapies, there is still a lack of a comprehensive discourse. This article attempts to summarize the mechanisms of action of various cytokines and provide a therapeutic overview of the current targeted therapies for HLH.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cytokine inhibitor; Cytokine storm; Hemophagocytic lymphohistiocytosis; IFN-γ; Targeted therapy

Year:  2022        PMID: 35819695     DOI: 10.1007/s12026-022-09285-w

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  99 in total

1.  Familial haemophagocytic reticulosis.

Authors:  J W FARQUHAR; A E CLAIREAUX
Journal:  Arch Dis Child       Date:  1952-12       Impact factor: 3.791

2.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

Review 3.  Pediatric hemophagocytic lymphohistiocytosis.

Authors:  Scott W Canna; Rebecca A Marsh
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

Review 4.  Similar but not the same: Differential diagnosis of HLH and sepsis.

Authors:  Rafał Machowicz; Gritta Janka; Wieslaw Wiktor-Jedrzejczak
Journal:  Crit Rev Oncol Hematol       Date:  2017-03-23       Impact factor: 6.312

Review 5.  Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.

Authors:  Anna Hayden; Sujin Park; Dean Giustini; Agnes Y Y Lee; Luke Y C Chen
Journal:  Blood Rev       Date:  2016-05-20       Impact factor: 8.250

6.  Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden.

Authors:  Marie Meeths; AnnaCarin Horne; Magnus Sabel; Yenan T Bryceson; Jan-Inge Henter
Journal:  Pediatr Blood Cancer       Date:  2014-11-08       Impact factor: 3.167

7.  Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Authors:  Elisabet Bergsten; AnnaCarin Horne; Maurizio Aricó; Itziar Astigarraga; R Maarten Egeler; Alexandra H Filipovich; Eiichi Ishii; Gritta Janka; Stephan Ladisch; Kai Lehmberg; Kenneth L McClain; Milen Minkov; Scott Montgomery; Vasanta Nanduri; Diego Rosso; Jan-Inge Henter
Journal:  Blood       Date:  2017-09-21       Impact factor: 22.113

8.  Clinical Characteristics of Adult Hemophagocytic Lymphohistiocytosis in the Emergency Department.

Authors:  Fang-Jie Zhang; Guo-Qing Huang; Jia Li; Ji Xu; Xiang-Min Li; Ai-Min Wang
Journal:  Int J Gen Med       Date:  2021-08-20

9.  Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race.

Authors:  J Allyson Niece; Zora R Rogers; Naveed Ahmad; Anne-Marie Langevin; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

Review 10.  How to Treat Involvement of the Central Nervous System in Hemophagocytic Lymphohistiocytosis?

Authors:  AnnaCarin Horne; Ronny Wickström; Michael B Jordan; E Ann Yeh; Ahmed Naqvi; Jan-Inge Henter; Gritta Janka
Journal:  Curr Treat Options Neurol       Date:  2017-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.